Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LIVMARLI

MARALIXIBAT CHLORIDE

Standard Dose
EQ 30MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LIVMARLI is listed in Drugs@FDA under application 219485 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MARALIXIBAT CHLORIDE Form and strength TABLET;ORAL - EQ 30MG BASE Sponsor MIRUM Submission history Latest submission status date: 2025-04-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview LIVMARLI is listed in Drugs@FDA under application 219485 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MARALIXIBAT CHLORIDE Form and strength TABLET;ORAL - EQ 30MG BASE Sponsor MIRUM Submission history Latest submission status date: 2025-04-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.